Download presentation
Presentation is loading. Please wait.
Published byAngelina Bartlett Modified over 11 years ago
1
Progress Against Ovarian Cancer
2
1970–1979
3
Progress Against Ovarian Cancer 1970–1979 1978: First effective combination chemotherapy regimen for ovarian cancer 1978: Cisplatin approved for advanced ovarian cancer
4
Progress Against Ovarian Cancer 1980–1989
5
Progress Against Ovarian Cancer 1980–1989 1981: Oral contraceptives found to cut ovarian cancer risk
6
Progress Against Ovarian Cancer 1980–1989 Mid-1980s: Scientists discover ''biomarker'' tied to ovarian cancer – CA-125
7
Progress Against Ovarian Cancer 1980–1989 1989: FDA approves carboplatin for ovarian cancer
8
Progress Against Ovarian Cancer 1990–1999
9
Progress Against Ovarian Cancer 1990–1999 1992–1994: Taxanes emerge as vital chemotherapy option for ovarian, breast cancer
10
Progress Against Ovarian Cancer 1990–1999 1996: New chemotherapy drug for advanced ovarian cancer
11
Progress Against Ovarian Cancer 1990–1999 Late 1990s: BRCA1 and BRCA2 gene mutations linked to increased ovarian cancer risk
12
Progress Against Ovarian Cancer 1990–1999 1999: FDA approves liposomal doxorubicin for advanced ovarian cancer
13
Progress Against Ovarian Cancer 2000–Present
14
Progress Against Ovarian Cancer 2000–Present 2003: New chemotherapy regimen – docetaxel and paclitaxel – provides important treatment option
15
Progress Against Ovarian Cancer 2000–Present 2005: Researchers work to decode the ovarian cancer genome
16
Progress Against Ovarian Cancer 2000–Present 2006: Researchers find some ovarian cancers begin in the fallopian tubes 2006: Direct chemotherapy approach increases survival
17
Progress Against Ovarian Cancer 2000–Present Late 2000s: Researchers identify at least two ovarian cancer subtypes
18
Progress Against Ovarian Cancer 2000–Present 2009: Preventive surgery confirmed to reduce breast and ovarian cancer risk in women with BRCA gene mutations
19
Progress Against Ovarian Cancer 2000–Present 2010: Regular CA125 testing to monitor for ovarian cancer recurrence is questioned 2010: Bevacizumab significantly delays progression of advanced ovarian cancer 2010: Pre-surgery chemotherapy proven an effective option for women with advanced ovarian cancer
20
Progress Against Ovarian Cancer Five-Year Survival Source: National Cancer Institute
21
Progress Against Ovarian Cancer Mortality Source: National Cancer Institute
22
Progress Against Ovarian Cancer New Cases Source: National Cancer Institute
23
Visit CancerProgress.Net for an interactive timeline of progress against a range of common cancers CancerProgress.Net is a project of the American Society of Clinical Oncology, which represents nearly 30,000 physicians who treat people with cancer and research new cures
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.